Synthetic Genomics, Venter Institute Form Vaccines Firm

The new venture also will work with Novartis on accelerating the production of influenza seed strains required for vaccine manufacturing.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.